We reported that HEYL is overexpressed in approximately 40% of breast cancer epithelial cells, and HEYL promoted breast cancer development by binding to TGFβ-activated Smads and inhibiting TGFβ activity (32). The gene discussed is HEYL; the disease is breast carcinoma.